centessa - Robuta Search

https://markets.financialcontent.com/stocks/article/marketminute-2026-4-6-lillys-78-billion-centessa-bet-inside-the-race-to-dominate-the-sleep-markets-orexin-gold-rush FinancialContent - Lilly’s $7.8 Billion Centessa Bet: Inside the Race to Dominate the Sleep... Apr 6, 2026 - Lilly’s $7.8 Billion Centessa Bet: Inside the Race to Dominate the Sleep Market’s ‘Orexin Gold Rush’ 7 8 billion financialcontent centessa bet inside https://centessa.com/orexin-agonist-orx750/ Orexin Agonist (ORX750) - Centessa Pharmaceuticals Feb 10, 2026 - Orexin Receptor 2 Agonist Program Building a class-leading franchise of orexin receptor 2 (OX2R) agonists for multiple neuroscience disorders Orexin agonists... agonist centessa pharmaceuticals https://www.biospace.com/deals/lilly-wakes-up-sleep-market-with-6-3b-centessa-buy-to-challenge-takeda Lilly Wakes Up Sleep Market With $6.3B Centessa Buy To Challenge Takeda - BioSpace Mar 31, 2026 - In the buyout, Eli Lilly picks up Centessa Pharmaceuticals’ lead asset cleminorexton, which could go toe-to-toe with Takeda’s oveporexton, currently under FDA... lilly wakes sleep market 6 https://markets.financialcontent.com/stocks/quote?Symbol=537%3A2578303213 FinancialContent - Centessa Pharmaceuticals plc - American Depositary Shares (Nasdaq:CNTA) Stock... View live stock data, charting, and news for Centessa Pharmaceuticals plc - American Depositary Shares (Nasdaq:CNTA) american depositary shares pharmaceuticals plc financialcontent centessa nasdaq https://www.genengnews.com/topics/translational-medicine/lilly-acquires-centessa-for-up-to-7-8b-biogen-buys-apellis-for-up-to-6-1b/ Lilly Acquires Centessa for Up to $7.8B; Biogen Buys Apellis for Up to $6.1B Mar 31, 2026 - Eli Lilly agrees to acquire sleep disorder drug developer Centessa Pharmaceuticals for approximately $7.8 billion, while Biogen agrees to purchase Apellis... 7 8b 6 1b lilly acquires centessa